ScoreWhy is BioSyent, Inc. ?
1
High Management Efficiency with a high ROE of 18.15%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 7.50
3
With a growth in Net Profit of 32.91%, the company declared Very Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at CAD 8.4 MM
- ROCE(HY) Highest at 22.35%
- INTEREST COVERAGE RATIO(Q) Highest at 29,741.41
4
With ROE of 21.64%, it has a fair valuation with a 4.45 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 37.78%, its profits have risen by 21.4% ; the PEG ratio of the company is 0.9
5
Consistent Returns over the last 3 years
- Along with generating 37.78% returns in the last 1 year, the stock has outperformed S&P/TSX 60 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to BioSyent, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is BioSyent, Inc. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
BioSyent, Inc.
36.44%
7.71
31.86%
S&P/TSX 60
23.72%
1.55
15.31%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.72%
EBIT Growth (5y)
12.58%
EBIT to Interest (avg)
7.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.96
Tax Ratio
25.74%
Dividend Payout Ratio
29.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
100.69%
ROE (avg)
18.15%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
4.45
EV to EBIT
14.22
EV to EBITDA
13.17
EV to Capital Employed
9.23
EV to Sales
3.66
PEG Ratio
0.91
Dividend Yield
NA
ROCE (Latest)
64.92%
ROE (Latest)
21.64%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD 8.4 MM
ROCE(HY)
Highest at 22.35%
INTEREST COVERAGE RATIO(Q)
Highest at 29,741.41
INVENTORY TURNOVER RATIO(HY)
Highest at 1.79 times
DIVIDEND PER SHARE(HY)
Highest at CAD 7.85
NET SALES(Q)
Highest at CAD 12.22 MM
OPERATING PROFIT(Q)
Highest at CAD 3.61 MM
OPERATING PROFIT MARGIN(Q)
Highest at 29.54 %
PRE-TAX PROFIT(Q)
Highest at CAD 3.65 MM
NET PROFIT(Q)
Highest at CAD 2.68 MM
EPS(Q)
Highest at CAD 0.23
-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 7.85 times
Here's what is working for BioSyent, Inc.
Operating Cash Flow
Highest at CAD 8.4 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Interest Coverage Ratio
Highest at 29,741.41
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at CAD 12.22 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CAD MM)
Net Sales
At CAD 12.22 MM has Grown at 23.73%
over average net sales of the previous four periods of CAD 9.88 MMMOJO Watch
Near term sales trend is positive
Net Sales (CAD MM)
Operating Profit
Highest at CAD 3.61 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CAD MM)
Operating Profit Margin
Highest at 29.54 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CAD 3.65 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD 2.68 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
EPS
Highest at CAD 0.23
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CAD)
Inventory Turnover Ratio
Highest at 1.79 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Dividend per share
Highest at CAD 7.85
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CAD)
Here's what is not working for BioSyent, Inc.
Debtors Turnover Ratio
Lowest at 7.85 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
